Conference abstractPublished 16 May 2016
Comparison of the One-Year Outcomes of Conbercept Therapy Between Two Different Angiographic Subtypes of Polypoidal Choroidal Vasculopathy
Peking University, China
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Objectives: To compare the outcomes of Conbercept therapy between two different angiographic subtypes of Polypoidal Choroidal Vasculopathy (PCV) Methods: Fifty-eight patients of PCV were classified into two phenotypes according to indocyanine green angiography (ICGA). In type-1, both feeder and draining vessels are visible on ICGA and network vessels are numerous. In type-2, neither feeder nor draining vessels are detectable and the number of network vessels is small. The patients were treated with intravitreal Conbercept (IVC) for 3 months. Additional IVC was given at subsequent monthly visits, if needed. The patients were followed-up for 12 months and changes in mean BCVA, central retinal thickness (CRT), serous retinal detachment (SRD), hemorrhage and number of Polypoidal lesions were evaluated. Results: The mean BCVA in type-2 PCV (15.92±9.7614.10±9.07) achieved a significantly greater improvement in than the type-1 (14.10±9.07) at month 12 (p<0.01). And the mean CRT decrease was numerically greater in type-2 (120.44±73.81) compared with type-1 (106.48±72.33) at month 6 (p<0.01) and greater in type-2 (130.21±76.28) compared with type-1 (111.67±79.57) at month 9 (p<0.01). There was no significant difference between the two groups for the decrease in SRF thickness, PED height and regression of polyps from month 3 to 12 (p>0.05). Conclusions: Classification systems for PCV will show differences in presentation, natural history or response to anti-VEGF treatment and might therefore provide a new key to the choice of treatment of the disease.
Ask about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- BylineArticles whose byline prints “Yong Cheng”